NewsRoom Articles - Page 34 of 154 - PsychedelicNewsWire (PNW)

MondayApr 10, 2023 1:45 pm

Connecticut Legislators Pass Bill Decriminalizing Psilocybin

A Connecticut legislative committee recently approved a measure to decriminalize possessing small amounts of magic mushrooms. The legislation reclassifies the possession of up to half an ounce of psilocybin mushrooms as a civil infraction with a $150 fine. Repeat offenders would be charged higher fines ranging from $200 to $500, and those who were convicted three times for psilocybin possession would be directed to a drug-education program. Joint Committee on Judiciary cochair Representative Steven Stafstrom said that although the measure does not legalize psilocybin outright or allow for therapeutic and recreational use, the legislation acknowledges the fact that psilocybin possession…

ThursdayApr 06, 2023 3:45 pm

Study Shows US Special Forces Veterans Experience Decreased PTSD, Alcohol Misuse After Psychedelic Treatment

A recent study has found that U.S. Special Forces veterans who underwent psychedelic treatment had lower levels of PTSD and alcohol misuse. Military veterans are much more likely to experience mental health conditions such as PTSD and depression, but existing treatments aren’t always effective. Psychedelics are poised to play a major role in the evolution of the psychiatric industry over the next decade as researchers work to develop safer and more effective treatments. Research into psychedelic drugs including psilocybin, mescaline and MDMA has found that they can alleviate the symptoms of several mental health conditions with minimal side effects. Hallucinogenics’…

WednesdayApr 05, 2023 2:04 pm

Sequel to ‘Have a Good Trip’ Goes into Production

Good Trip Studios has announced that it has begun producing a sequel to the documentary “Have a Good Trip: Adventures in Psychedelics.” The 2020 documentary was written and directed by Emmy-winning writer, director and producer Donick Cary and hosted by Nick Offerman. The film, which included a cast of more than 30 celebrities sharing anecdotes about their experiences with hallucinogenic drugs, was released on Netflix in May 2020. Comedy writer Donick Cary says he was inspired to write “Have a Good Trip” after talking about hallucinogenics and people’s experiences while under the influence with Fisher Stevens and Ben Stiller at…

TuesdayApr 04, 2023 2:33 pm

First Psilocybin Facilitator Cohort Completes Course at Changa Institute

The first psychedelic facilitators at the Changa Institute passed their final exams. The 13 individuals will become the first physicians in the United States to be licensed to guide patients through psychedelic experiences outside of clinical trials. A recent surge in psychedelic research has revealed that hallucinogenic drugs can potentially treat certain mental health disorders. These studies have found that when paired with talk therapy, psychedelic treatment can offer long-term relief against conditions such as depression and post-traumatic stress disorder (PTSD). However, since the psychedelic-assisted therapy segment is still entirely new, there are rarely any clinicians trained to guide patients…

MondayApr 03, 2023 2:02 pm

Massachusetts Legislator Files Bill Capping MDMA Therapy Costs

A Massachusetts legislator has filed a bill that seeks to cap the cost of MDMA therapy. Recent research into the potential effects of psychedelics has found that the substances can treat various health conditions with minor side effects. They seem to be especially effective against mental health issues such as major depressive disorder and post-traumatic stress disorder (PTSD), which often fail to respond to conventional treatment. With most Americans reporting that the country is in the midst of a major mental health crisis, the psychedelic renaissance couldn’t have come at a better time. However, due to extremely limited availability, psychedelic-assisted…

FridayMar 31, 2023 2:55 pm

VIC Researcher Looks into Using Psychedelics to Combat Intergenerational Trauma

A growing body of scientific literature has revealed that psychedelic drugs such as ketamine, MDMA and psilocybin may have therapeutic potential. Researchers have found in recent years that these hallucinogens may be able to alleviate the symptoms of certain mental health disorders when accompanied by talk therapy. Furthermore, psychedelics seem to deliver these mental health benefits after relatively little doses and with few side effects. Major investors including pharmaceutical companies are now investing millions of dollars into psychedelic research to be the first to develop psychedelic-based treatments. According to Vancouver Island University researchers, tapping into indigenous knowledge will be key…

ThursdayMar 30, 2023 1:52 pm

Canadian Patients Sue Federal Government for Psilocybin Therapy Access

Psilocybin-assisted therapy has recently emerged as a potential treatment for certain mental health disorders amid a global surge in psychedelic research. Research has found that psilocybin, the main hallucinogenic agent in magic mushrooms, may be able to alleviate the effects of anxiety and depression as well as treat alcohol and nicotine-use dependence. However, most countries have classified psilocybin and most other psychedelic drugs as controlled substances with no accepted medical use. This has made it nigh impossible for mental health patients to access psilocybin without having to take part in clinical trials or shell out thousands of dollars to travel…

WednesdayMar 29, 2023 2:19 pm

Controversy Grows Over Necessity of Hallucinogenic Experiences During Psychedelic Therapy

The past few years have seen the emergence of a relatively new and controversial mode of treatment in the psychiatric sector: psychedelic-assisted therapies. As more scientists across the country have turned their attention to psychedelics and its possible benefits, a growing body of research has revealed that hallucinogenics such as ketamine, psilocybin and MDMA have the potential to treat various mental health disorders. Since the research comes when the country is in the midst of a mental health crisis and plenty of Americans are interested in safer and more effective mental health treatments, psychedelic-assisted therapies have seen a significant surge…

TuesdayMar 28, 2023 1:25 pm

Study Suggests Bad Psychedelic Trips May Confer Mental Health Benefits Too

A new paper published in the “Journal of Affective Disorders” suggests that “bad” psychedelic trips may have a positive effect on mental health. The study represents the first research to delve deeper into the psychedelic experience and break it down into subtypes. Psychedelics have been subject to increased scientific scrutiny in recent years after initial studies indicated that they may have mental health benefits. This research has revealed that psychedelic experiences can result in major neural changes that can impact mental health in positive ways. With only a single or few doses of a psychedelic such as psilocybin, ketamine or…

TuesdayMar 28, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into the Feasibility of Using Ketamine Formulations as an Alternative Treatment for Fibromyalgia

Silo Pharma recently provided an update on an ongoing study delving into the potential use of SP-26 as an alternative treatment for fibromyalgia The study, which is being carried out in conjunction with Experimur, has looked into the feasibility of using a time-released, dosage-controlled formulation of ketamine as a suitable treatment for the chronic medical condition Since its founding, Silo Pharma has rapidly gained a reputation for its innovative approach towards seeking solutions to address a variety of underserved medical conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000